Pathogenesis from Inflammation to Cancer in NASH-Derived HCC

Area of Science:

• Hepatology and Oncology
• Molecular Biology
• Pathogenesis of Liver Disease

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally.
• Non-alcoholic steatohepatitis (NASH) is a growing cause of chronic liver disease.
• A subset of NASH patients develop HCC without cirrhosis, highlighting unique carcinogenic pathways.

Purpose of the Study:

• To elucidate the mechanisms linking NASH to HCC development.
• To understand how metabolic dysregulation and inflammation in NASH promote tumorigenesis.
• To review the transition from liver inflammation to cancer in NASH-derived HCC.

Main Methods:

• Literature review of studies on NASH and HCC pathogenesis.
• Analysis of molecular and cellular pathways involved in NASH-induced liver injury.
• Synthesis of current understanding of inflammation-to-cancer transition in the liver.

Main Results:

• NASH involves metabolic dysfunction, chronic inflammation, and hepatocyte death.
• These factors create a pro-tumorigenic microenvironment in the liver.
• Inflammation-driven pathways are critical in NASH-associated HCC, even without cirrhosis.

Conclusions:

• NASH represents a distinct pathway to HCC, independent of cirrhosis in some cases.
• Understanding these mechanisms is crucial for developing targeted therapies for NASH-derived HCC.
• Further research into NASH pathogenesis can improve early detection and prevention strategies.